NPCE neuropace.com Market Cap to Net Assets Ratio

Official company branding of NeuroPace Inc (NPCE)

NeuroPace, Inc. (NPCE) creates a comprehensive neurostimulation environment for epilepsy, where AI-based software paired with implants makes it extremely difficult for clinics to switch to competitors. The uniqueness of these real-time systems allows the company to maintain premium pricing power. This daily price chart complements revenue data dependent on the number of procedures, while liquidity stands at 37.04.

NPCE NeuroPace Medical: Market Value to Book Value in the range 07/04/2022 - 10/27/2026
Original product of NeuroPace Inc

For NeuroPace, Inc. (NPCE), whose value is increasing through the scaling of high-margin software sales and post-implantation consumables, the change in the market value to book capitalization ratio reflects a market revaluation of intellectual capital. This coefficient is calculated as the quotient of the total market capitalization to equity, demonstrating the investor premium over net book value and assessing the business's growth potential.

Competitor analysis

Market Capitalization to Book Value Ratio DXCM|Market-to-Book Ratio penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|Inspire Sleep (INSP) - Market Capitalization to Book Value Ratio|Market Value to Book Value Procept (PRCT)|CNMD: Market Capitalization to Book Value Ratio|pulsebiosciences.com - Market-to-Book Ratio|Market Value to Book Value Ratio InMode (INMD)|PMI - Market Value to Book Value|SRDX: Market Capitalization to Book Value Ratio|SENS (Senseonics Holdings, Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Tactile Systems Technology, Inc. TCMD|Market Capitalization to Net Assets sanuwave.com|Outset Medical - Market Capitalization to Book Value Ratio|Market-to-Book Ratio smartvest.com ELMD|Market Cap to Net Assets Ratio LNSR (LENSAR, Inc)|RCEL - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Profound Medical Corporation PROF|BDMD - Market Cap to Book Value Multiple|edap-tms.com - Market Capitalization to Book Value Ratio|Apyx Medical Corporation (APYX) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ICCM|Market Cap to Net Assets Ratio Pulmonx Corp. (LUNG)|TELA Bio, Inc. (TELA) - Market Cap to Net Assets Ratio|Market Value to Book Value CTSO (cytosorbents.com)|Sensus Healthcare - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Zynex Medical ZYXI|ECOR (electroCore Medical) - Market Capitalization to Book Value Ratio|RBOT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio inspira-technologies.com|seastarmedical.com (ICU) - Capitalization to Book Value Ratio|IRIX: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Intelligent Bio|Market Capitalization to Book Value Ratio XAIR (Beyond Air, Inc.)|Market Cap to Net Assets Ratio Profusa, Inc (PFSA)|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|GlucoTrack Inc. - Market Capitalization to Book Value Ratio|NAOV - Market Value to Book Value Ratio|Venus Concept Inc (VERO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Market Value to Book Value|Market Capitalization to Book Value Ratio ASXC (Asensus Surgical Inc)|Market-to-Book Ratio AVGR|BSGM: Market Value to Book Value Ratio|Market Value to Equity Ratio Cutera Inc. CUTR|Market Cap to Net Assets Ratio KNW (Know Labs Corp)|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)